source
- Novo Nordisk CFO describes roller-coaster growth and stays optimistic about CagriSema after Q2 earningsNovo Nordisk CFO Karsten Munk Knudsen talked to Fierce after the company released its second-quarter earnings, reflecting on his nine-year tenure and the firm’s volatile performance. He recalled a…
- Fresenius Kabi recalls one lot of Morphine Sulfate Injection after labeling error mixes Dilaudid syringesFresenius Kabi announced a voluntary recall of a single lot of its Morphine Sulfate Injection USP, Simplist 2 mg/1 mL product. The recall stems from a labeling mistake where the MicroVault contain…